Vorsitzende: E. Grube (Siegburg), T. Walther (Leipzig)
| (V496) | Evaluation of the diastolic left ventricular function after Ross procedures in patients with aortic regurgitation and stenosis. Echocardiographic long-term follow up of 9 years |
|
|
T. Wittlinger, O. Dzemali, P. Kleine, F. Bakhtiary, A. Moritz (Dresden, Frankfurt am Main) |
| (V497) | Management of procedural complications associated with transcatheter aortic valve implantation |
|
|
S. Bleiziffer, H. Ruge, D. Mazzitelli, C. Schreiber, A. Opitz, A. Hutter, P. Tassani-Prell, R. Bauernschmitt, R. Lange (München) |
| (V498) | Percutaneous Aortic Valve Replacement With the CoreValve ReValving System in High-risk Patients With Aortic Stenosis |
|
|
A. Linke, T. Walther, D. Schloma, R. Höllriegel, S. Möbius-Winkler, M. Woinke, J. Ender, F. W. Mohr, G. C. Schuler (Leipzig) |
| (V499) | Six- months follow-up of the mulitcenter, European PARTNER registry |
|
|
V. Schächinger, T. Lefevre, P. de Jaegere, A. P. Kappetein, B. De Bruyne, F. P. Casselman, S. Sack, M. Thielmann, A. Cribier, J.-P. Bessou, G. Wimmer-Greinecker , PARTNER EU (Frankfurt am Main, München, Essen, Bad Bevensen; Massy, Rouen, FR; Rotterdam, Aalst, BE) |
| (V500) | Conventional aortic valve replacement in elderly and high risk patient. What is the bench mark? |
|
|
A. Diegeler, P. Urbanski, J. Babin Ebell, O. Friesewinkel, F. Lakew, W. Dinstak, S. Klügl, M. Zacher (Bad Neustadt a. d. Saale, Freiburg im Breisgau) |
| (V501) | Mid-term effect of transfemoral, transcatheter aortic valve implantation on plasma B-type natriuretic peptide in patients with severe aortic stenosis. |
|
|
M. Weber, P. Kahlert, F. Al-Rashid, D. Wendt, M. Thielmann, H. Eggebrecht, S. Sack, R. Erbel (Essen, München) |